Constrained bithiazoles

Small molecule correctors of defective δf508-CFTR protein trafficking

Keith C. Coffman, Huy H. Nguyen, Puay Wah Phuan, Brandi M. Hudson, Gui J. Yu, Alex L. Bagdasarian, Deanna Montgomery, Michael W. Lodewyk, Baoxue Yang, Choong L. Yoo, A. S. Verkman, Dean J. Tantillo, Mark J. Kurth

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Conformationally constrained bithiazoles were previously found to have improved efficacy over nonconstrained bithiazoles for correction of defective cellular processing of the δF508 mutant cystic fibrosis transmembrane conductance regulator (CFTR) protein. In this study, two sets of constrained bithiazoles were designed, synthesized, and tested in vitro using δF508-CFTR expressing epithelial cells. The SAR data demonstrated that modulating the constraining ring size between 7-versus 8-membered in these constrained bithiazole correctors did not significantly enhance their potency (IC50), but strongly affected maximum efficacy (Vmax), with constrained bithiazoles 9e and 10c increasing Vmax by 1.5-fold compared to benchmark bithiazole corr4a. The data suggest that the 7-and 8-membered constrained ring bithiazoles are similar in their ability to accommodate the requisite geometric constraints during protein binding.

Original languageEnglish (US)
Pages (from-to)6729-6738
Number of pages10
JournalJournal of Medicinal Chemistry
Volume57
Issue number15
DOIs
StatePublished - Aug 14 2014

Fingerprint

Cystic Fibrosis Transmembrane Conductance Regulator
Protein Transport
Benchmarking
Protein Binding
Inhibitory Concentration 50
Epithelial Cells
Proteins
In Vitro Techniques

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery
  • Medicine(all)

Cite this

Coffman, K. C., Nguyen, H. H., Phuan, P. W., Hudson, B. M., Yu, G. J., Bagdasarian, A. L., ... Kurth, M. J. (2014). Constrained bithiazoles: Small molecule correctors of defective δf508-CFTR protein trafficking. Journal of Medicinal Chemistry, 57(15), 6729-6738. https://doi.org/10.1021/jm5007885

Constrained bithiazoles : Small molecule correctors of defective δf508-CFTR protein trafficking. / Coffman, Keith C.; Nguyen, Huy H.; Phuan, Puay Wah; Hudson, Brandi M.; Yu, Gui J.; Bagdasarian, Alex L.; Montgomery, Deanna; Lodewyk, Michael W.; Yang, Baoxue; Yoo, Choong L.; Verkman, A. S.; Tantillo, Dean J.; Kurth, Mark J.

In: Journal of Medicinal Chemistry, Vol. 57, No. 15, 14.08.2014, p. 6729-6738.

Research output: Contribution to journalArticle

Coffman, KC, Nguyen, HH, Phuan, PW, Hudson, BM, Yu, GJ, Bagdasarian, AL, Montgomery, D, Lodewyk, MW, Yang, B, Yoo, CL, Verkman, AS, Tantillo, DJ & Kurth, MJ 2014, 'Constrained bithiazoles: Small molecule correctors of defective δf508-CFTR protein trafficking', Journal of Medicinal Chemistry, vol. 57, no. 15, pp. 6729-6738. https://doi.org/10.1021/jm5007885
Coffman KC, Nguyen HH, Phuan PW, Hudson BM, Yu GJ, Bagdasarian AL et al. Constrained bithiazoles: Small molecule correctors of defective δf508-CFTR protein trafficking. Journal of Medicinal Chemistry. 2014 Aug 14;57(15):6729-6738. https://doi.org/10.1021/jm5007885
Coffman, Keith C. ; Nguyen, Huy H. ; Phuan, Puay Wah ; Hudson, Brandi M. ; Yu, Gui J. ; Bagdasarian, Alex L. ; Montgomery, Deanna ; Lodewyk, Michael W. ; Yang, Baoxue ; Yoo, Choong L. ; Verkman, A. S. ; Tantillo, Dean J. ; Kurth, Mark J. / Constrained bithiazoles : Small molecule correctors of defective δf508-CFTR protein trafficking. In: Journal of Medicinal Chemistry. 2014 ; Vol. 57, No. 15. pp. 6729-6738.
@article{e871f86b5cb34fa289e8379235142a49,
title = "Constrained bithiazoles: Small molecule correctors of defective δf508-CFTR protein trafficking",
abstract = "Conformationally constrained bithiazoles were previously found to have improved efficacy over nonconstrained bithiazoles for correction of defective cellular processing of the δF508 mutant cystic fibrosis transmembrane conductance regulator (CFTR) protein. In this study, two sets of constrained bithiazoles were designed, synthesized, and tested in vitro using δF508-CFTR expressing epithelial cells. The SAR data demonstrated that modulating the constraining ring size between 7-versus 8-membered in these constrained bithiazole correctors did not significantly enhance their potency (IC50), but strongly affected maximum efficacy (Vmax), with constrained bithiazoles 9e and 10c increasing Vmax by 1.5-fold compared to benchmark bithiazole corr4a. The data suggest that the 7-and 8-membered constrained ring bithiazoles are similar in their ability to accommodate the requisite geometric constraints during protein binding.",
author = "Coffman, {Keith C.} and Nguyen, {Huy H.} and Phuan, {Puay Wah} and Hudson, {Brandi M.} and Yu, {Gui J.} and Bagdasarian, {Alex L.} and Deanna Montgomery and Lodewyk, {Michael W.} and Baoxue Yang and Yoo, {Choong L.} and Verkman, {A. S.} and Tantillo, {Dean J.} and Kurth, {Mark J.}",
year = "2014",
month = "8",
day = "14",
doi = "10.1021/jm5007885",
language = "English (US)",
volume = "57",
pages = "6729--6738",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "15",

}

TY - JOUR

T1 - Constrained bithiazoles

T2 - Small molecule correctors of defective δf508-CFTR protein trafficking

AU - Coffman, Keith C.

AU - Nguyen, Huy H.

AU - Phuan, Puay Wah

AU - Hudson, Brandi M.

AU - Yu, Gui J.

AU - Bagdasarian, Alex L.

AU - Montgomery, Deanna

AU - Lodewyk, Michael W.

AU - Yang, Baoxue

AU - Yoo, Choong L.

AU - Verkman, A. S.

AU - Tantillo, Dean J.

AU - Kurth, Mark J.

PY - 2014/8/14

Y1 - 2014/8/14

N2 - Conformationally constrained bithiazoles were previously found to have improved efficacy over nonconstrained bithiazoles for correction of defective cellular processing of the δF508 mutant cystic fibrosis transmembrane conductance regulator (CFTR) protein. In this study, two sets of constrained bithiazoles were designed, synthesized, and tested in vitro using δF508-CFTR expressing epithelial cells. The SAR data demonstrated that modulating the constraining ring size between 7-versus 8-membered in these constrained bithiazole correctors did not significantly enhance their potency (IC50), but strongly affected maximum efficacy (Vmax), with constrained bithiazoles 9e and 10c increasing Vmax by 1.5-fold compared to benchmark bithiazole corr4a. The data suggest that the 7-and 8-membered constrained ring bithiazoles are similar in their ability to accommodate the requisite geometric constraints during protein binding.

AB - Conformationally constrained bithiazoles were previously found to have improved efficacy over nonconstrained bithiazoles for correction of defective cellular processing of the δF508 mutant cystic fibrosis transmembrane conductance regulator (CFTR) protein. In this study, two sets of constrained bithiazoles were designed, synthesized, and tested in vitro using δF508-CFTR expressing epithelial cells. The SAR data demonstrated that modulating the constraining ring size between 7-versus 8-membered in these constrained bithiazole correctors did not significantly enhance their potency (IC50), but strongly affected maximum efficacy (Vmax), with constrained bithiazoles 9e and 10c increasing Vmax by 1.5-fold compared to benchmark bithiazole corr4a. The data suggest that the 7-and 8-membered constrained ring bithiazoles are similar in their ability to accommodate the requisite geometric constraints during protein binding.

UR - http://www.scopus.com/inward/record.url?scp=84906081074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906081074&partnerID=8YFLogxK

U2 - 10.1021/jm5007885

DO - 10.1021/jm5007885

M3 - Article

VL - 57

SP - 6729

EP - 6738

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 15

ER -